Furthermore, among various types of CKM progression, elevated TyG was primarily associated with an increased risk of future diabetes, metabolic syndrome, and hypertriglyceridemia, while its direct association with CVD progression was not statistically significant. The gene discussed is CKM; the disease is hypertriglyceridemia.